Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4Other solid neoplasm 1

Conditions

Breast Neoplasms 3100Neoplasms 2446Carcinoma, Non-Small-Cell Lung 1865Prostatic Neoplasms 1629Colorectal Neoplasms 1424Lung Neoplasms 1300Multiple Myeloma 930Neoplasm Metastasis 926Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 851Ovarian Neoplasms 803Melanoma 786Carcinoma, Hepatocellular 743Stomach Neoplasms 640Brain Neoplasms 640Recurrence 635Squamous Cell Carcinoma of Head and Neck 631Head and Neck Neoplasms 614Glioblastoma 569Lymphoma 543Uterine Cervical Neoplasms 541Triple Negative Breast Neoplasms 505Precursor Cell Lymphoblastic Leukemia-Lymphoma 498Carcinoma, Renal Cell 497Hematologic Neoplasms 467Urinary Bladder Neoplasms 462Endometrial Neoplasms 462Colonic Neoplasms 439Sarcoma 437Lymphoma, Non-Hodgkin 437

Interventions

Temozolomide 1Paclitaxel 1Dacarbazine 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Advanced Melanoma × 1 year × Clear all
NCT07310784 2026-05-12

A Phase II Trial of LM103 in Advanced Melanoma

Suzhou BlueHorse Therapeutics Co., Ltd.

Phase 2 Recruiting
92 enrolled
Dermatologic

Advanced Melanoma

NCT05869539 2026-02-27

BaseTIL-03M

University Hospital, Basel, Switzerland

Phase 1 Active not recruiting
10 enrolled
Dermatologic

Advanced Melanoma

NCT05098184 2025-12-11

A Study of GC101 TIL in Advanced Melanoma (10hospital)

Shanghai Juncell Therapeutics

Phase EARLY_PHASE1 Recruiting
50 enrolled
Dermatologic

Advanced Melanoma

NCT07107178 2025-08-06

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

Biotroy Therapeutics

Phase 1 Not yet recruiting
58 enrolled
DermatologicOther solid neoplasm

Advanced Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡